The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
Open accessAbstract
The dose-response relationship between elevated plasma free fatty acid (FFA) levels and impaired insulin-mediated glucose disposal and insulin signaling was examined in 21 lean, healthy, normal glucose-tolerant subjects. Following a 4-h saline or Liposyn infusion at 30 (n = 9), 60 (n = 6), and 90 (n = 6) ml/h, subjects received a 2-h euglycemic insulin (40 mU · m−2 · min−1) clamp. Basal plasma FFA concentration (∼440 μmol/l) was increased to 695, 1,251, and 1,688 μmol/l after 4 h of Liposyn infusion and resulted in a dose-dependent reduction in insulin-stimulated glucose disposal (Rd) by 22, 30, and 34%, respectively (all P < 0.05 vs. saline control). At the lowest lipid infusion rate (30 ml/h), insulin receptor and insulin receptor substrate (IRS)-1 tyrosine phosphorylation, phosphatidylinositol (PI) 3-kinase activity associated with IRS-1, and Akt serine phosphorylation were all significantly impaired (P < 0.05–0.01). The highest lipid infusion rate (90 ml/h) caused a further significant reduction in all insulin signaling events compared with the low-dose lipid infusion (P < 0.05–0.01) whereas the 60-ml/h lipid infusion caused an intermediate reduction in insulin signaling. However, about two-thirds of the maximal inhibition of insulin-stimulated glucose disposal already occurred at the rather modest increase in plasma FFA induced by the low-dose (30-ml/h) lipid infusion. Insulin-stimulated glucose disposal was inversely correlated with both the plasma FFA concentration after 4 h of lipid infusion (r = −0.50, P = 0.001) and the plasma FFA level during the last 30 min of the insulin clamp (r = −0.54, P < 0.001). PI 3-kinase activity associated with IRS-1 correlated with insulin-stimulated glucose disposal (r = 0.45, P < 0.01) and inversely with both the plasma FFA concentration after 4 h of lipid infusion (r = −0.39, P = 0.01) and during the last 30 min of the insulin clamp (r = −0.43, P < 0.01). In summary, in skeletal muscle of lean, healthy subjects, a progressive increase in plasma FFA causes a dose-dependent inhibition of insulin-stimulated glucose disposal and insulin signaling. The inhibitory effect of plasma FFA was already significant following a rather modest increase in plasma FFA and develops at concentrations that are well within the physiological range (i.e., at plasma FFA levels observed in obesity and type 2 diabetes).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both acute (4 hours) and chronic (4 days) physiologic elevation of plasma FFA concentration in insulin sensitive individuals impairs insulin signaling and causes insulin resistance in skeletal muscle [28, 62–68].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [65]
In the citing paper
“It is well established that chronically elevated plasma FFA levels cause insulin resistance in skeletal muscle [1, 12, 14, 62–65].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [65]
In the citing paper
“The inhibition of insulin signaling and induction of skeletal muscle insulin resistance caused by elevation in the plasma FFA concentration is dose dependent [65].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [65]
In the citing paper
“Such observations are most likely attributed to testosterone-induced changes in lipid metabolism and/or altered postreceptor insulin signaling in muscle (54) and also improved insulin sensitivity enhancing muscle lipid uptake (55).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Cited by
Sorted by citations
Items 101–200 of 404
Abdul‐Ghani, M. A., Molina‐Carrión, M., Jani, R., Jenkinson, C. P., & DeFronzo, R. A. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0033-z · Cited by 63
Self-citationRemodeling Lipid Metabolism and Improving Insulin Responsiveness in Human Primary Myotubes
Sparks, L. M., Moro, C., Ukropcová, B., Bajpeyi, S., Civitarese, A. E., Hulver, M. W., Thoresen, G. H., Rustan, A. C., & Smith, S. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021068 · Cited by 64
Sandberg, J. C., Björck, I., & Nilsson, A. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151985 · Cited by 64
Mancia, G., Bombelli, M., Facchetti, R., Madotto, F., Corrao, G., Trevano, F. Q., Giannattasio, C., Grassi, G. M., & Sega, R. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328302f10d · Cited by 58
Liang, H., Tantiwong, P., Sriwijitkamol, A., Shanmugasundaram, K., Mohan, S., Espinoza, S. E., DeFronzo, R. A., Dubé, J. J., & Musi, N. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.247510 · Cited by 59
Self-citationOpposite Regulation of Insulin Sensitivity by Dietary Lipid Versus Carbohydrate Excess
Lundsgaard, A., Sjøberg, K. A., Høeg, L. D., Jeppesen, J. F., Jordy, A. B., Serup, A. K., Fritzen, A. M., Pilegaard, H., Myrmel, L. S., Madsen, L., et al. (2017) · Diabetes · doi:10.2337/db17-0046 · Cited by 61
A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
Rudge, J. D. (2022) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210299 · Cited by 58
Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C2C12myotubes
Kadotani, A., Tsuchiya, Y., Hatakeyama, H., Katagiri, H., & Kanzaki, M. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00293.2009 · Cited by 62
Todd, M. K., Watt, M. J., Le, J., Hevener, A. L., & Turcotte, L. P. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00080.2006 · Cited by 58
Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction
Benito‐Vicente, A., Jebari‐Benslaiman, S., Galicia-García, U., Larrea, A., Uribe, K. B., & Martín, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.013 · Cited by 59
Insulin Resistance and Endothelial Dysfunction: A Mutual Relationship in Cardiometabolic Risk
Turco, S. D., Gaggini, M., Daniele, G., Basta, G., Folli, F. B., Sicari, R., & Gastaldelli, A. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319130010 · Cited by 58
Inflammation and Metabolic Complications in HIV
Bourgi, K., Wanjalla, C. N., & Koethe, J. R. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0411-2 · Cited by 56
Chen, Y., Wang, Y., Zhang, J., Sun, C., & López, A. (2011) · ISRN Endocrinology · doi:10.5402/2011/519371 · Cited by 60
The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome
Manning, P. J., Sutherland, W. H. F., Williams, S., Walker, R. J., Berry, E. A., de Jong, S. A., & Ryalls, A. R. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.11.006 · Cited by 55
Feng, X., Tian-Zhan, W. A. N. G., Leng, J., Chen, Y., Ji-Bo, L. I. U., Liu, Y., & Wang, W. (2012) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.120107 · Cited by 56
Xi, L., Qian, Z., Xu, G., Zhou, C., & Sun, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707276 · Cited by 53
Harris, L.-A. L. S., Smith, G. I., Patterson, B. W., Ramaswamy, R. S., Okunade, A. L., Kelly, S. C., Porter, L. C., Klein, S., Yoshino, J., & Mittendorfer, B. (2017) · Diabetes · doi:10.2337/db16-1475 · Cited by 52
Methylxanthines and Human Health: Epidemiological and Experimental Evidence
Beaudoin, M., & Graham, T. E. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_21 · Cited by 54
Chavez, A. O., Kamath, S., Jani, R., Sharma, L. K., Monroy, A., Abdul-Ghani, M. A., Centonze, V. E., Sathyanarayana, P., Coletta, D. K., Jenkinson, C. P., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1387 · Cited by 52
Self-citationChow, L. S., From, A. H. L., & Seaquist, E. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.009 · Cited by 54
Ross, J. S., Hu, W. M., Rosen, B. P., Snider, A. J., Obeid, L. M., & Cowart, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.477786 · Cited by 58
Lipid metabolism in patients with chronic hyperglycemia after an episode of acute pancreatitis
Gillies, N. A., Pendharkar, S. A., Singh, R. G., Asrani, V. M., & Petrov, M. S. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.037 · Cited by 51
Risk Factors for Preeclampsia in Women from Colombia: A Case-Control Study
Reyes, L. M., Garcia, R. G., Ruiz, S. L., Camacho, P. A., Ospina, M. B., Aroca, G., Accini, J., & López-Jaramillo, P. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041622 · Cited by 50
Serlie, M. J. M., Meijer, A. J., Groener, J. E. M., Durán, M., Endert, E., Fliers, E., Aerts, J. M. F. G., & Sauerwein, H. P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2347 · Cited by 51
Gormsen, L. C., Jessen, N., Gjedsted, J., Gjedde, S., Nørrelund, H., Lund, S. A., Christiansen, J. S., Nielsen, S., Schmitz, O., & Møller, N. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2659 · Cited by 48
Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children
Tagi, V. M., Mainieri, F., & Chiarelli, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105814 · Cited by 48
Fiorenza, M., Onslev, J., Henríquez‐Olguín, C., Persson, K. W., Hesselager, S. A., Jensen, T. E., Wojtaszewski, J. F. P., Hostrup, M., & Bangsbo, J. (2024) · Science Advances · doi:10.1126/sciadv.adq4461 · Cited by 58
Merovci, A., Abdul‐Ghani, M. A., Mari, A., Solis‐Herrera, C., Xiong, J., Daniele, G., Tripathy, D., & DeFronzo, R. A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2597 · Cited by 48
Self-citationFernyhough, P., & McGavock, J. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00027-8 · Cited by 50
Molero, J. C., Waring, S. G., Cooper, A., Turner, N. A., Laybutt, D. R., Cooney, G. J., & James, D. E. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0312 · Cited by 45
Pátková, J., Anděl, M., & Trnka, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358709 · Cited by 46
Effect of metformin on bioactive lipid metabolism in insulin-resistant muscle
Zabielski, P., Chacińska, M., Charkiewicz, K., Baranowski, M., Górski, J., & Błachnio-Zabielska, A. U. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0381 · Cited by 46
Direct apoptotic effects of free fatty acids on human endothelial cells
Piro, S., Spampinato, D., Spadaro, L., Oliveri, C. E., Purrello, F., & Rabuazzo, A. M. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.009 · Cited by 45
Metabolic syndrome: molecular mechanisms and therapeutic interventions
Zheng, L., Zeng, A., Liu, L., Tian, W., Wang, R., Zhang, L., Hua, H., & Zhao, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00303-5 · Cited by 48
Emmanuel, Y., Cochlin, L. E., Tyler, D. J., de Jager, C. A., Smith, A. D., & Clarke, K. (2013) · Brain and Behavior · doi:10.1002/brb3.124 · Cited by 44
Glucose and lipid metabolism disorders in the chickens with dexamethasone‐induced oxidative stress
Lv, Z., Peng, Y., Zhang, B., Fan, H., Liu, D., & Guo, Y. ‐. (2017) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12823 · Cited by 44
Muscle adaptation to short-term fasting in healthy lean humans
Soeters, M. R., Sauerwein, H. P., Dubbelhuis, P. F., Groener, J. E., Ackermans, M. T., Fliers, E., Aerts, J. M., & Serlie, M. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0250 · Cited by 40
Pros and cons of fatty acids in bone biology
Wauquier, F., Léotoing, L., Philippe, C., Spilmont, M., Coxam, V., & Wittrant, Y. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.03.001 · Cited by 41
The Role of Skeletal Muscle Sphingolipids in the Development of Insulin Resistance
Strączkowski, M., & Kowalska, I. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.13 · Cited by 43
Adipose Tissue Metabolic Function and Dysfunction: Impact of Burn Injury
Kaur, S., Auger, C., & Jeschke, M. G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.599576 · Cited by 39
Insulin-Stimulated Muscle Glucose Uptake and Insulin Signaling in Lean and Obese Humans
Ramos, P. A., Lytle, K. A., Delivanis, D. A., Nielsen, S., LeBrasseur, N. K., & Jensen, M. D. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa919 · Cited by 40
Beaudoin, M., Robinson, L. E., & Graham, T. E. (2011) · Journal of Nutrition · doi:10.3945/jn.110.132761 · Cited by 40
Zhang, Y., Fu, Y., Jiang, T., Liu, B., Sun, H., Zhang, Y., Fan, B., Li, X., Qin, X., & Zheng, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.771940 · Cited by 38
Yang, L., Qian, Z., Ji, H., Yang, R., Wang, Y., Liang, X., Sheng, L., Zhao, B., & Zhang, X. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.05.061 · Cited by 38
Cardiac glycogen accumulation after dexamethasone is regulated by AMPK
Puthanveetil, P., Wang, F., Kewalramani, G., Kim, M. S., Hosseini‐Beheshti, E., Ng, N., Lau, W., Pulinilkunnil, T., Allard, M. F., Abrahani, A., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.518.2008 · Cited by 38
Handy, R. M., & Holloway, G. P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1151389 · Cited by 38
“Importantly, this increase in circulating NEFA appears to be suffucient for the development of whole-body glucose intolerance, evidenced by acute lipid oversupply experiments utilizing intralipid and heparin infusions in humans (Boden et al., 1994; Dresner et al., 1999; Belfort et al., 2005) and rodents (Yu et al.”
BackgroundZhou, H., Liu, L., Zhang, Y., Huang, Y., Tao, Y., Zhang, S., Su, J., Tang, Y., Guo, Z., Hu, R., et al. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12068 · Cited by 37
Park, G. S. H., Jung, S., Wellen, K. E., & Jang, C. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00614-x · Cited by 37
Havekes, B., & Sauerwein, H. P. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833e341d · Cited by 37
Zhang, N., Liang, H., Farese, R. V., Li, J., Musi, N., & Hussey, S. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132575 · Cited by 36
Błachnio-Zabielska, A. U., Hady, H. R., Markowski, A. R., Kurianiuk, A., Karwowska, A., Górski, J., & Zabielski, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123995 · Cited by 36
DeFronzo, R. A., Mehta, R. J., & Schnure, J. J. (2013) · Hospital Practice · doi:10.3810/hp.2013.04.1062 · Cited by 35
Self-citationMechanism of Obesity-Related Lipotoxicity and Clinical Perspective
Engin, A. B. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_5 · Cited by 37
Joya-Galeana, J., Fernandez, M., Cervera, A., Reyna, S. M., Ghosh, S., Triplitt, C. L., Musi, N., DeFronzo, R. A., & Cersósimo, E. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1185 · Cited by 34
Self-citationZaky, A. S., Kandeil, M. A., Abdel‐Gabbar, M., Fahmy, E. M., Almehmadi, M. M., Ali, T. M., & Ahmed, O. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020263 · Cited by 33
Acute elevation of plasma lipids does not affect ATP synthesis in human skeletal muscle
Brehm, A., Krššák, M., Schmid, A. I., Nowotny, P., Waldhäusl, W. K., & Roden, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00756.2009 · Cited by 33
Lapauw, B., Ouwens, M., ′t Hart, L. M., Wuyts, B., Holst, J. J., T'Sjoen, G., Kaufman, J.-M., & Ruige, J. B. (2010) · Diabetes Care · doi:10.2337/dc10-0515 · Cited by 32
Steenberg, D. E., Hingst, J. R., Birk, J. B., Thorup, A., Kristensen, J. M., Sjøberg, K. A., Kiens, B., Richter, E. A., & Wojtaszewski, J. F. P. (2020) · Diabetes · doi:10.2337/db19-1010 · Cited by 32
The influence of major dietary fatty acids on insulin secretion and action
López, S., Bermúdez, B., Abia, R., & Muriana, F. J. G. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346d39 · Cited by 32
Pro-inflammatory cytokine-induced lipolysis after an episode of acute pancreatitis
Pendharkar, S. A., Singh, R. G., & Petrov, M. S. (2017) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2017.1415359 · Cited by 33
A sustained increase in plasma NEFA upregulates the Toll-like receptor network in human muscle
Hussey, S. E., Lum, H., Alvarez, A. V., Cipriani, Y., Garduño‐García, J. D. J., Anaya, L., Dubé, J. J., & Musi, N. (2013) · Diabetologia · doi:10.1007/s00125-013-3111-x · Cited by 32
Bouchouirab, F. Z., Fortin, M., Noll, C., Dubé, J., & Carpentier, A. C. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.09.002 · Cited by 31
Cersósimo, E., Xu, X., & Musi, N. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00022.2011 · Cited by 31
Collins, K. A., Ross, L. M., Slentz, C. A., Huffman, K. M., & Kraus, W. E. (2022) · Sports Medicine - Open · doi:10.1186/s40798-022-00480-5 · Cited by 39
Sasaki, N., Maeda, R., Ozono, R., Yoshimura, K., Nakano, Y., & Higashi, Y. (2022) · Hypertension Research · doi:10.1038/s41440-022-00987-0 · Cited by 33
Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth
Gordon, J. W., Dolinsky, V. W., Mughal, W., Gordon, G. R., & McGavock, J. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0012 · Cited by 30
Glucose Use in Fasted Rats Under Sevoflurane Anesthesia and Propofol Anesthesia
Sato, K., Kitamura, T., Kawamura, G., Mori, Y., Sato, R., Araki, Y., & Yamada, Y. (2013) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31829e4028 · Cited by 28
Fappi, A., & Mittendorfer, B. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665119001022 · Cited by 29
Koukoui, O., Dossa, C. P. A., Boucherie, S., Yovo, M., Nüße, O., Combettes, L., & Sohounhloué, D. (2015) · American Journal of Plant Sciences · doi:10.4236/ajps.2015.611177 · Cited by 29
López, X., Cypess, A. M., Manning, R., O'Shea, S., Kulkarni, R., & Goldfine, A. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0627 · Cited by 29
Omega-3 long-chain fatty acids strongly induce angiopoietin-like 4 in humans
Brands, M., Sauerwein, H. P., Ackermans, M. T., Kersten, S., & Serlie, M. J. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m030049 · Cited by 29
Makimura, H., Stanley, T. L., Suresh, C., Sousa‐Coelho, A. L. D., Frontera, W. R., Syu, S., Braun, L. R., Looby, S. E. D., Feldpausch, M. N., Torriani, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3696 · Cited by 29
Lipoprotein metabolism and vascular complications in pregnancy
Huda, S. S., Sattar, N. A., & Freeman, D. J. (2009) · Clinical Lipidology · doi:10.2217/17584299.4.1.91 · Cited by 28
Lindegaard, B., Frøsig, C., Petersen, A. M. W., Plomgaard, P., Ditlevsen, S., Mittendorfer, B., van Hall, G., Wojtaszewski, J. F. P., & Pedersen, B. K. (2007) · Diabetes · doi:10.2337/db07-0144 · Cited by 27
Zhou, J., Wei, Y., Zhang, L., Zhang, J., Guo, L.-Y., Gao, C., Li, D., & Zhang, Y. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0059 · Cited by 27
Bódis, K. B., Jeleník, T., Lundbom, J., Markgraf, D. F., Strom, A., Zaharia, O., Karusheva, Y., Burkart, V., Müssig, K., Kupriyanova, Y., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz267 · Cited by 29
Ross, L. M., Slentz, C. A., Sudnick, A. M., Huffman, K. M., SHALAUROVA, I. Y., Otvos, J. D., Connelly, M. A., Kraus, V. B., Bales, C. W., Houmard, J. A., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.626142 · Cited by 28
Freda, P. U. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.933039 · Cited by 28
A role for oleoylethanolamide in chronic lymphocytic leukemia
Masoodi, M., Lee, E., Eiden, M. J., Bahlo, A., Shi, Y., Ceddia, R. B., Baccei, C. S., Prasit, P., & Spaner, D. (2014) · Leukemia · doi:10.1038/leu.2014.10 · Cited by 27
Training status diverges muscle diacylglycerol accumulation during free fatty acid elevation
Chow, L. S., Mashek, D. G., Austin, E. E., Eberly, L. E., Persson, X.-M. T., Mashek, M. T., Seaquist, E. R., & Jensen, M. D. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00166.2014 · Cited by 27
Lucchinetti, E., Lou, P., Wawrzyniak, P., Wawrzyniak, M., Scharl, M. M., Holtzhauer, G., Krämer, S. D., Hersberger, M., Rogler, G., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901270 · Cited by 29
Petrick, H. L., Foley, K. P., Zlitni, S., Brunetta, H. S., Paglialunga, S., Miotto, P. M., Politis‐Barber, V., O’Dwyer, C., Philbrick, D. J., Fullerton, M. D., et al. (2020) · Function · doi:10.1093/function/zqaa013 · Cited by 27
Serum cholesteryl fatty acid composition and plasma glucose concentrations in Amerindian women
Lindgärde, F., Vessby, B. O., & Åhrén, B. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.5.1009 · Cited by 26
Holloway, G. P. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-028 · Cited by 25
Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus
Cusi, K. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0033-6 · Cited by 25
Self-citationValsdottir, T. D., Henriksen, C., Odden, N., Nellemann, B., Jeppesen, P. B., Hisdal, J., Westerberg, A. C., & Jensen, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01499 · Cited by 26
Feng, X., WANG, T.-Z., CHEN, Y., LIU, J.-B., Liu, Y., & Wang, W. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1061 · Cited by 24
Serlie, M. J. M., Allick, G., Groener, J. E. M., Ackermans, M. T., Heijligenberg, R., Voermans, B. C., Aerts, J. M. F. G., Meijer, A. J., & Sauerwein, H. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1518 · Cited by 24
Nonalcoholic Fatty Liver Disease
Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.014 · Cited by 53
Evolving perspectives on evaluating obesity: from traditional methods to cutting-edge techniques
Wang, H., Qin, Y., Niu, J., Chen, H., Lu, X., Wang, R., & Han, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2472856 · Cited by 26
Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review
DeFronzo, R. A., & Auchus, R. J. (2025) · Diabetes · doi:10.2337/db25-0120 · Cited by 31
Self-citationWhy Does Obesity Increase the Risk for Cardiovascular Disease?
Boden, G. H., & Salehi, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319320003 · Cited by 23
What are the pharmacotherapy options for treating prediabetes?
Daniele, G., Abdul‐Ghani, M. A., & DeFronzo, R. A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.944160 · Cited by 23
Self-citationSharbatdar, Y., Mousaviyan, R., Varnosfaderani, S. M. N., Aziziyan, F., Liaghat, M., Baziyar, P., Rad, A. Y., Tavakol, C., Moeini, A. M., Nabi‐Afjadi, M., et al. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01215-y · Cited by 24
β-Arrestins: multifunctional signaling adaptors in type 2 diabetes
Feng, X., Wang, W., Liu, J., & Liu, Y. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0389-3 · Cited by 23
Ripley, E. M., Clarke, G. D., Hamidi, V., MARTINEZ, R. A., Settles, F., Solis‐Herrera, C., Deng, S., Abdul‐Ghani, M. A., Tripathy, D., & DeFronzo, R. A. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00426.2017 · Cited by 23
Self-citationLv, Y., Zhang, J., Yang, T., Sun, J., Hou, J., Chen, Z., Yu, X., Yuan, X., Lu, X., Xie, T., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903731 · Cited by 22
Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes
Nicholas, D., Mbongue, J. C., Garcia-Pérez, D., Sorensen, D. W., Bennit, H. R. F., León, M. A. D., & Langridge, W. H. R. (2024) · Immuno · doi:10.3390/immuno4010006 · Cited by 22
Steffen, B. T., Steffen, L. M., Zhou, X., Ouyang, P., Weir, N. L., & Tsai, M. Y. (2015) · Diabetes Care · doi:10.2337/dc14-1919 · Cited by 22
Regulation of Intermediary Metabolism During Fasting and Feeding
DeFronzo, R. A., & Ferrannini, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00035-4 · Cited by 22
Self-citation
Metadata
- Authors
- Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., DeFronzo, R. A., & Cusi, K.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2005-06-01
- Volume
- 54
- Issue
- 6
- Pages
- 1640-1648
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2115433418
- Cited by
- 404
- References
- 74
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 22 · 2023: 10 · 2022: 18 · 2021: 21 · 2020: 24 · 2019: 15 · 2018: 14 · 2017: 20 · 2016: 15 · 2015: 23 · 2014: 28 · 2013: 26 · 2012: 15
- FWCI
- 11.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-24092, F32DK061189, R01DK024092)
- National Center for Research Resources (M01RR01346, M01RR001346)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- plasma free fatty acids, insulin signaling, insulin resistance, insulin-stimulated glucose disposal, dose-response relationship, insulin receptor tyrosine phosphorylation, IRS-1, phosphatidylinositol 3-kinase, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adult, Dose-Response Relationship, Drug, Emulsions, Fat Emulsions, Intravenous, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Male, Safflower Oil, Soybean Oil, Signal Transduction, Muscle, Skeletal, Lecithins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review